The<unk>  primarily affects young males. Preliminary studies suggest that prevalence may be 1.8 per 10,000 live male births. 50% of those affected do not live beyond 25 years of age, with deaths attributed to the impaired immune function.
MECP2 duplication syndrome
Cornelia de Lange syndrome
Ayazi syndrome
8p23.1 duplication syndrome
TORCH syndrome
SYNGAP1-related intellectual disability
22q11.2 duplication syndrome
ATR-16 syndrome